Designed for Pets. Trusted by Owners.
PETRACKR® was built from the ground up to meet the needs of diabetic cats and dogs — and the people who care for them.
PETRACKR® is developed by Universal Biosensors, a global leader in electrochemical diagnostics with over a billion clinical tests performed in human health. Our veterinary platform is built on the same science used in hospital-grade diagnostics — now adapted to meet the unique needs of dogs and cats living with diabetes.
We’ve combined decades of scientific expertise with real-world pet owner feedback to design a solution that puts simplicity and accuracy first.
Every year, thousands of pets are diagnosed with diabetes. But until now, home monitoring tools have either been adapted from human devices or limited to expensive, complex veterinary systems.
PETRACKR® fills that gap. Our goal is to make glucose testing as easy as feeding your pet — empowering you to manage their condition effectively, reduce unnecessary vet visits, and share real-time data with your vet to support better care decisions.
PETRACKR is more than just a product. We’re building a community of informed, empowered pet parents and veterinary partners who believe that managing diabetes can be simple and stress-free — without sacrificing accuracy or care.
Follow us, share your story, or contact our team anytime. We’re here to support every paw step of the way.
PETRACKR® puts you in control of your pet’s diabetes — with clinically backed accuracy, a complete starter kit, and an app that makes care collaboration with your vet effortless. Explore our products, and get started today.
Human glucometers shouldn’t be used for cats and dogs due to species-specific differences.
PETRACKR® is specifically designed for cats and dogs, ensuring accurate results and the best diabetic care for cats and dogs.
PETRACKR® has been validated by Top Tier University, a world-leading veterinary university, with 95% accuracy, meeting ISO15197:2013 human glucometer standards, but is calibrated for cats and dogs.
Our core technology consists of a disposable, multi-layer test strip, which incorporates a proprietary electrochemical sensing system using opposing electrodes that rapidly and accurately detects specific analytes in samples as small as a droplet (8μL). This innovative technology was developed in our high-end research and development laboratory.
A recent technology breakthrough has enhanced our detection limits by 1 billion times. Our technology offers affordable portability, speed, ease of use and reliability, with comparable precision and accuracy.
In 2011, Universal Biosensors began developing the Xprecia Stride™ blood coagulation analyzer in collaboration with Siemens Healthineers. Launched in 2015, Xprecia Stride™ was sold in 36 countries and currently has an install base exceeding 3,500 analyzers, servicing thousands of hospitals around the world. In 2022, Universal Biosensors launched Xprecia Prime™ in the EU and UK, the next-generation blood coagulation analyzer which replaces Xprecia Stride™. Xprecia Prime™ was launched in the US in 2024.
In 2021, Universal Biosensors successfully launched its unique handheld wine analyzer called Sentia™ with an initial test to measure free SO2. Subsequently, Universal Biosensors developed and launched tests for monitoring malic acid, glucose, fructose, titratable acidity, and acetic acid throughout the wine production process.
Universal Biosensors launched PETRACKR® in early 2023, a veterinary blood glucometer to monitor blood glucose in diabetic cats and dogs. These products will complement Universal Biosensors’ existing Canadian blood testing laboratory Hemostasis Reference Lab (HRL).
All our analyzers use the same trusted patented biosensor technology but adapted and calibrated for different industries. With over 10 billion tests performed globally using our technology, you can trust that PETRACKR® is the best product available on the market.